Cargando…
Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling
The non-steroidal anti-inflammatory agent, sulindac, has shown strong effects on cancer prevention in colorectal cancers, however, its anticancer activities on prostate cancer remain unclear. In the current study, human prostate cancer cell lines, LNCaP and PC-3, were treated with various concentrat...
Autores principales: | DU, JUN, GUO, YONGCHEN, BAO, YONGHUA, XING, MENGTAO, MAHMOUD, ABEER M., CHE, ZHENYONG, CHEN, ZHIGUO, YANG, WANCAI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063579/ https://www.ncbi.nlm.nih.gov/pubmed/24959268 http://dx.doi.org/10.3892/ol.2014.2084 |
Ejemplares similares
-
Regulation of c-Jun NH(2)-Terminal Kinase for Islet Transplantation
por: Noguchi, Hirofumi
Publicado: (2019) -
Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
por: Zhu, Xiangdong, et al.
Publicado: (2018) -
Krox-20 inhibits Jun-NH(2)-terminal kinase/c-Jun to control Schwann cell proliferation and death
por: Parkinson, David B., et al.
Publicado: (2004) -
Inhibition of c-Jun NH(2)-terminal kinase or extracellular signal-regulated kinase improves lung injury
por: Lee, Hui Su, et al.
Publicado: (2004) -
Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)